Moonview Sanctuary Releases First Case Study of Client Treated Using Unique Moon...(f life. For more information concern...),Health
Navigation Links
Moonview Sanctuary Releases First Case Study of Client Treated Using Unique Moonview Model
Date:5/29/2008
f life."
For more information concerning Moonview Sanctuary and its unique treatment method, please visit http://www.moonviewsanctuary.com. To read the complete case study, please visit http://moonviewsanctuary.com/pdfs/Article%20%201.pdf.
About Moonview Sanctuary
Moonview Sanctuary is an exclusive, non-residential treatment and optimal performance center which specializes in combining Eastern and Western approaches. These modalities include Western practices such as psychiatry, psychology and neuroscience, in tandem with Eastern philosophies such as yoga, meditation and Chinese medicine. Moonview offers the ultimate therapy experience, with an expert group of practitioners, all authorities in their field, working synergistically on a single client, couple or family. This customized approach provides the most private and confidential treatment possible to help clients heal, restore balance and enrich their lives.
'/>"/>
| SOURCE Moonview Sanctuary Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. High-End Treatment Center Moonview Sanctuary Unveils Four New Core Treatment Programs
2. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
5. Verdict One Releases Directory of Board Certified Attorneys for Consumers
6. Academy releases emergency preparedness tools to enable millions more people to shelter in place
7. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
8. MITEM Releases Blue Iris eLaborate 8.6
9. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
Post Your Comments:
(Date:12/4/2009)... Dec. 4 The following i...inz Family Philanthropies: ,, Credit Senators J...gnificant contribution to the health care debate: ...ns living with Phenylketonuria (PKU) control their...rs living with serious chronic conditions are trea...
(Date:12/4/2009)... ischemic stroke are at higher lifetime risk for a... reduce that risk. One of the simplest regimens in... as blood thinners, of which the most common is as...whether the use of antithrombotic medications amon...iod found that in each of the years, approximately...
(Date:12/4/2009)... Tender Corp., a leading manufacturer of over-the...gned to enhance consumers’ quality of life, ...ed American Podiatric Medical Association (APMA) S..., HealthiFeet®. , (P...manufacturer of over-the-counter topical cream and...
(Date:12/4/2009)...Ind., Dec. 4 Hill-Rom Ho...scal 2010 first quarter dividend of $0.1025 per sh...d of Directors on December 3, 2009, and is payable...s of December 17, 2009. ,, ABOUT HILL-ROM ...wide manufacturer and provider of medical technolo...
(Date:12/4/2009)...nn., Dec. 4 MedClean Tec...nnounced the Company has entered into a preferred ..., LLC, a Delaware limited liability company, doin...LLC. Pursuant to the Purchase Agreement, MedClean ... The Company agreed to sell up to 750 shares of it...
Breaking Medicine News(10 mins):Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Are stroke survivors taking their medicine? 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 3[0] Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move[0] Are stroke survivors taking their medicine?[0] Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval[0] Hill-Rom Announces First Quarter 2010 Dividend[0] MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million
...y College London and Imperial College London have ...sy environment, such as a pub or in a crowd. // Th...ain work together to make sense of what it hears, ...perience of people who rely on cochlear implants, ...
...tting ready to go home.
Savage, who received ...mber last, says he feels sensation in his// new li...and in a ghastly machine press accident.
Savag...ansplant surgeries.
Savage, who reported sensa...
...r educated about the risks of exposing children to...h researchers.//
Results from a 14-year stu...e more likely to suffer respiratory problems.
...rn Australia say the evidence supports a ban on sm...
...ommended a maximum residue limit (MRL) of one part... the panel has suggested that the limit should be ...nsumer safety.
The panel is headed by the ch...f a controversy over pesticide residues in colas. ...
... issue in quality of life for patients with chroni...peaker, advocate and rheumatology patient, is// ou...nals address this aspect of care. During an hour-l... experiences. Perhaps most importantly, she’ll be ...
...rs seem to have tapped nature, in the form of an e...a possible cure for a notorious type of childhood/...a accounts for nearly 3% of all cancers in childre...'Brien of the University of California, San Franci...
Other Medicine News:Health News:Making Sense of the World Through a Cochlear Implant 2Health News:Destroying Taboos to Improve Patient Care 2(Date:12/3/2009)...c. 3 Radiology imaging leader MEDR...ration capabilities at the November 2009 Radiology...t.PACS(TM) product, enabling the first radiology ...t release in the company,s newly branded Certegra...://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
(Date:12/3/2009).... 3 Wound Management...rapidly growing provider of specialty medical prod... Industry Representative Association (HIRA) to ser...ing representative to market the company,s core Ce...IRA will market and sell Wound Management Technolo...
(Date:12/3/2009)...re-FirstCall/ -- Cardium Therapeutics (NYSE Amex: ...diary, Tissue Repair Company, submitted a 510(k) p...d Drug Administration (FDA) seeking marketing clea...sed on positive data from the Company,s recently c...submission with the FDA covers Excellagen XL(TM) ...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 1Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 2Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 1SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 2SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 4SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 5SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 6SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 7SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 8SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 9SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 10Combo Treatment May Ease Depression After Stroke 53891 1Combo Treatment May Ease Depression After Stroke 53891 2[0] MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009[0] Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up[0] Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
...ONTO, Feb. 15 A seven-year, international,study p...es such as,acupuncture, neck manipulation and mass...ck pain than many current practices. Also included...exercises, education, neck,mobilization, low level...h as neck collars and ultrasound are not recommend...
...TH SAN FRANCISCO, Calif., Feb. 15 Cell,Genesys, I...an analysis,examining the potential association be...rostate cancer and increased patient survival in a...e refractory prostate cancer,(HRPC). More than 400...were,identified in the sera of the treated patient...
Other Medicine Technology:Seven-Year Neck Pain Study Sheds Light on Best Care 2Seven-Year Neck Pain Study Sheds Light on Best Care 3Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 3Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 4Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |